226 publications
| Name | Date | Type | Actions |
|---|---|---|---|
SALES FOR 1ST QUARTER 2025 First-quarter sales of Essential products totaled 85 million euros, up+ 1.8% at constant exchange rates. |
Public releases | ||
Availability of the 2024 universal registration document On 24 April 2025, Vetoquinol filed its 2024 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
Public releases | ||
Buyback programs - March 2025 Monthly communication regarding buyback programs |
Liquidity contract , Description of buyback programs | ||
2024 Annual results Annual sales: €539m (+2.2% at constant exchange rates) |
Public releases | ||
Buyback programs - February 2025 Monthly communication regarding buyback programs |
Liquidity contract , Description of buyback programs | ||
Buyback programs - January 2025 Monthly communication regarding buyback programs |
Liquidity contract , Description of buyback programs | ||
Annual sales 2024: €539 million Annual sales: €539 million (up 2.2% at constant exchange rates and up 1.9%. on a reported basis) |
Public releases | ||
Buyback programs - December 2024 Monthly communication regarding buyback programs |
Liquidity contract , Description of buyback programs | ||
Buyback programs - November 2024 Monthly communication regarding buyback programs |
Liquidity contract , Description of buyback programs | ||
Buyback programs - October 2024 Monthly communication regarding buyback programs |
Liquidity contract , Description of buyback programs |